biostudies-literatureUnknown8(23)Sun LY<h4>Email</h4>zhangchengwuzr@hotmail.com; Prof. Tian Yang, MD. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China. Email: yangtiandfgd@hotmail.com.<h4>Background</h4>Identifying patients at high risks of developing postoperative morbidity is important to improve perioperative outcomes. We sought to define the accuracy of two objective and non-invasive serological-based scores, i.e., albumin-bilirubin (ALBI) and aspartate transaminase-to-platelet ratio index (APRI), to predict postoperative morbidity among patients undergoing hepatectomy for hepatocellular carcinoma (HCC), and build up a personalized predictive tool for clinical practice.<h4>Methods</h4>Clinical data of patients who underwent hepatectomy for HCC at 8 Annals of translational medicine1591https://www.ebi.ac.uk/biostudies/studies/S-EPMC7791207biostudies-literatureA novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma.PMC7791207Diao YKZhou YHLi JSun LYLi CZhu HPawlik TMShen FGu WMXing HLiang LZeng YYYang TChen THZhang CWLau WYfalseA novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma.<h4>Email</h4>zhangchengwuzr@hotmail.com; Prof. Tian Yang, MD. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China. Email: yangtiandfgd@hotmail.com.<h4>Background</h4>Identifying patients at high risks of developing postoperative morbidity is important to improve perioperative outcomes. We sought to define the accuracy of two objective and non-invasive serological-based scores, i.e., albumin-bilirubin (ALBI) and aspartate transaminase-to-platelet ratio index (APRI), to predict postoperative morbidity among patients undergoing hepatectomy for hepatocellular carcinoma (HCC), and build up a personalized predictive tool for clinical practice.<h4>Methods</h4>Clinical data of patients who underwent hepatectomy for HCC at 8 2020-01-01T00:00:00Z2020 Dec2025-04-05T16:11:24.339Z2025-04-05T16:11:24.339ZS-EPMC77912073343779010.21037/atm-20-1421